Zoetis
ZTS
$173.28
Share price
2.61%
Change (1 day)
-5.75%
Change (1 year)
Categories
Zoetis (ZTS) - Cash on Hand
Cash on Hand as of March 2024 : $1.97 B
According to Zoetis's latest financial reports the company has $1.97 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Zoetis - Cash on Hand chart (from 2011 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $2.03 B | -43% |
| 2022-12-31 | $3.57 B | 2.73% |
| 2021-12-31 | $3.48 B | -3.33% |
| 2020-12-31 | $3.60 B | 86.44% |
| 2019-12-31 | $1.93 B | 13.92% |
| 2018-12-31 | $1.69 B | 8.44% |
| 2017-12-31 | $1.56 B | 115.13% |
| 2016-12-31 | $0.72 B | -37% |
| 2015-12-31 | $1.15 B | 30.84% |
| 2014-12-31 | $0.88 B | 44.59% |
| 2013-12-31 | $0.61 B | 92.43% |
| 2012-12-31 | $0.31 B | 301.27% |
| 2011-12-31 | $79 M | 25.4% |
| 2010-12-31 | $63 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $12.69 B | 543.18% | 🇺🇸 USA |
 Eli Lilly LLY | $2.58 B | 31.08% | 🇺🇸 USA |
 Sanofi SNY | $9.92 B | 403.20% | 🇫🇷 France |
 Merck MRK | $7.09 B | 259.50% | 🇺🇸 USA |
 Phibro Animal Health
PAHC | $92.49 M | -95.31% | 🇺🇸 USA |
 Kindred Biosciences
KIN | N/A | N/A | 🇺🇸 USA |
 Heska Corporation
HSKA | $0.12 B | -93.65% | 🇺🇸 USA |